drugset / Trial / NCT07699601

Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery

NCT07699601

Phase 2/3 Recruiting 330 enrolled Shanghai Huilun Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery.

Timeline

Start
2026-05-09
Primary completion
2026-10
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule Oral
Subject HL-1186 Unknown Oral
Comparator Oxycodone Other / unclassified Oral

Indications

No indication recorded.